GRTX/ 04/14/2026 · 10:22 AM Obsidian Therapeutics to Merge with Galera and Raise $350 Million to Advance TIL Cell Therapy Galera and Obsidian merge to form OBX, advancing TIL cancer therapy for melanoma & lung cancer, backed by $350M funding.